FRESENIUS Drug Research via One Search

Drug Market Analysis

Labels - Marketing Product 0

Approvals - Approved FDA Filings 0

API - Active Pharmaceutical Ingredients Filings 0

Tentative Approvals 0

There are 0 marketed drugs that starts with fresenius leveraging 0 FDA filings. To produce the drug products fresenius there are 0 registered Active Pharmacuetical Ingredients (APIs). There is also currently 0 tentative approval(s) which could be another future market entrant. The full list of this data can be seen here with an exportable excel file and easy access to the product insert and product labels. Our data is sourced through a combination of openFDA, orangebook and proprietary linking logic.

Hmmm, there are not any people marketing fresenius . Plese try your search again

Hmmm, there were no FDA approvals returned for the search fresenius . Plese try your search again

Hmmm, there were no API filings returned for fresenius . Plese try your search again

Tentative approvals are typically a filing that is ready to approve but waiting for a patent or exclusivity period to expire prior to approval. Information on tentatively approved drug can inform pharma companies of future entrants that may impact thier go to market staregy or inform business development experts of companies that may be looking for a partner to bring a tentatively approved drug to the market.

We did not find any tentative approvals for the search fresenius

We have been able to locate the private label and GPO suppliers for the following highlighted labels. Click on the details to see the private label supplier

BluePoint Civica Intalere Northstar NovaPlus Premier Schien (HF or GI)

Vertically integrated analysis is completed by searchong for companies with the FDA approved drug filings and an API (Drug Master Filings) on record. That list includes...

Drug Supply Analysis

FDA Shortages - Listings on FDA Shortage List 0

Recalls - Recalls on product (abridged) 0

483s - Drug Mentioned in 483s 0

Compounders - Compounders Making This Drug 0

How Made - Report on Manufacturing Process 0

Drug supply is evaluated upon many factors from current status and process to manufacture. fresenius has 0 listings on the FDA drug shortage list. In addition, there are 0 recalls on file for fresenius. Another area of interest could be if fresenius is mentioned in any FDA 483s. fresenius is mentioned in 0 483s. Also, to meet patient needs it appears there are 0 compounded forms of fresenius. To see more information on how is made we do have access to 0 production files out of Europe which could be a good proxy for production.

There were no FDA drug shortage listings for your the search fresenius .

Recalling firms and dates include We were not able to locate and drug recalls for the search fresenius . Our database reflects that of the publically available FDA recalls but that list is not comprehensive

FDA 483 forms are the forms to close out inspections and they note any FDA observations. We were not able to locate any FDA form 483s for this search

Compounders, often reffered to as 503b compounders, prepare and modify drugs to be in a more final form for use by health care practitioners and patients. We were not able to locate any compounders of product for this search.

One method to access manufactuing process is to use filings out of Europe which publish manufacturing data. We were not able to locate any of these reports for this search.

Drug Exclusivity Analysis

Patents - Drug Patents 0

Exclusivity - FDA Exclusivity 0

PIV - Paragraph IV Drug Files 0

Drug exclusivity for fresenius is evaluated based on Orange Book Patents, Paragraph IV filings and FDA Exclusivity. Currently there are 0 orange book patents, 0 FDA exclusivities and 0 paragraph IV filings. Further analysis can be seen in the additional tabs

We were not able to locate any drug patents for the search fresenius

The FDA offers drug exclusivities for products such as Orphan Drug Exclusivity (ODE) – 7 years, New Chemical Entity Exclusivity (NCE) – 5 years, Generating Antibiotic Incentives Now (GAIN) Exclusivity – 5 years added to certain exclusivities, New Clinical Investigation Exclusivity – 3 years, Pediatric Exclusivity (PED) – 6 months added to existing Patents/Exclusivity, Patent Challenge (PC) – 180 days (this exclusivity is for ANDAs only), Competitive Generic Therapy (CGT) - 180 days (this exclusivity is for ANDAs only).

There were no FDA exclusivities located for the serach fresenius

We were not able to locate any paragraph four (PIV) drug patent statuses for this search fresenius

Drug Partnership Analysis

Shared Filings 0

GPO/Private Labels Identified 0

Often pharmaceutical filings are shared by many marketing organizations and not just virtual pharma companies. There are 0 companies sharing FDA filngs and we have been able to trace back GPO / private labes for 0 filings for fresenius . See details in the tabs to the right

We have been able to locate that there are 0 shared filings for the search fresenius

Go To Shared Filings for fresenius Marketers Go To Shared Filings for fresenius Marketers

We have been able to locate the private label and GPO suppliers for the following highlighted labels. Click on the details to see the private label supplier

BluePoint Civica Intalere Northstar NovaPlus Premier Schien (HF or GI)

Drug Pricing Analysis

FSS - Federal Supply Schedule Pricing 0

NADAC - National Drug Acquisition Cost 0

Pharmaceutical pricing is not very transparent. The two available sources to use are the federal supply schedule and National Average Drug Acquisition Cost, if it exists. Federal supply schedule pricing traditionally gives insight into the more accurate and lower cost of the product in the market. The prefered and more accurage source is the FSS schedule low and there are 0 vendors on the Federal Supply Schedule contract. The full table can be seen here on the FSS tab and in the detailed table. The National Average Drug Acquisition cost was located for 0 listings. The details can be seen in NADAC details.

We were not able to locate any Federal Supply Schedule (FSS) pricing for the search term fresenius . Federal supply schedule drug pricing sets the pricing paid by the many government entities.

The National Average Drug Acquisition Cost or NADAC sets some key reimbursement rates of drugs.

We did not have any NADAC's for the search fresenius .

Drug Promotions Analysis

Advertising - Available Relevant Ads 0

Warnings - Product Warning and Precautions Coming soon

We have 0 promotional materials for the search fresenius . Promotional ads are highly regulated and based off of OpenFDA this product has specific warnings and risks called out.

We have no pharmaceutical ads on file for the search fresenius .